Interphase cytogenetic diagnosis of bladder cancer on cells from urine and bladder washing

International Journal of Oncology

Volumn 14, Issue 2, 1999, Pages 309-313

  Junker, Kerstin ^a  

^a Department of Urology ^*  (Germany)

Author keywords

Bladder cancer; Fluorescence in situ hybridization; Genetics; Recurrent disease

Indexed keywords

ARTICLE; BLADDER; BLADDER TUMOR; CENTROMERE; CHROMOSOME ABERRATION; CYTOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; TRANSITIONAL CELL CARCINOMA; URINE;

CARCINOMA, TRANSITIONAL CELL; CENTROMERE; CHROMOSOME ABERRATIONS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; URINARY BLADDER; URINARY BLADDER NEOPLASMS; URINE;

EID: 0033072694     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.2.309     Document Type: Article

References (14)

1. Soloway MS: Managing superficial bladder cancer: an overview. Urology 40: 5-10, 1992.
2. Holmäng S, Hedelin H, Anderström C and Johansson SL: The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 153: 1823-1895, 1995.
3. Liu BCS, Weiss RE, Gordon JN, et al: Biology of metastasis: clinical implications. Semin Surg Oncol 8: 267-273, 1992.
4. Sack MJ, Artymyshyn RL, Tomaszewski JE and Gupta PK: Diagnostic value of bladder wash cytology, with special reference to low grade urothelial neoplasms. Acta Cytol 2: 187-194, 1995.
5. Sandberg A and Berger S: Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. J Urol 151: 545-560, 1994.
6. Miyao N, Tsai YC, Lerner SP, et al: Role of chromosome 9 in human bladder cancer. Cancer Res 53: 4066-4070, 1993.
7. Ruppert JM, Tokino K and Sidransky D: Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res 53: 1230-1232, 1993.
8. Orlow I, Lianes P, Lavombe L, et al: Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res 54: 2848-2851, 1994.
9. Kallioniemi A, Kallioniemi O, Citro G, Sauter G, De Vries S, Kerschmann R, et al: Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer 12: 213-219, 1995.
10. Simoneau AR, Spruck CH, Gonzalez-Zulueta M, et al: Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and initial screening for GASI and PTC mutations. Cancer Res 56: 5039-5043, 1996.
11. Presti JC, Reuter VE, Galan T, et al: Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 51: 5405-5409, 1991.
12. Cairns P, Saw ME and Knowles MA: Initiation of bladder cancer may involve deletion of a tumor suppresor gene on chromosome 9. Oncogene 8: 1083-1085, 1993.
13. Cajulis RS, Heines IGK, Frias-Hidvegi D and McVary K: Interphase cytogenetics as an adjuvant in the cytodiagnosis of urinary bladder carcinoma. Anal Quant Cytol Histol 16: 1-10, 1994.
14. Meloni MM, Peier AM, Hadard FS, Powell IJ, Block AMW, Huben RP, et al: A new approach in the diagnosis and follow-up of bladder cancer. Cancer Genet Cytogenet 71: 105-118, 1993.